Avalo Therapeutics, a biotech company focused on IL-1β pathway therapeutics for inflammatory diseases, announced its management will participate in the Guggenheim Healthcare Innovation Conference and the Stifel 2026 Healthcare Conference in November 2026. These events will include fireside chats where the company will discuss its lead drug candidate, abdakibart, currently in phase 3 trials for hidradenitis suppurativa, and other development programs. Live webcasts will be available on Avalo's investor website, providing updates to investors and stakeholders. This participation highlights Avalo's ongoing efforts to advance its clinical programs and engage with the investment community.
Avalo Therapeutics news is presented with Health-sector market data for context. For readers following Health stocks, 48 of 150 US stocks rose and 100 fell on Pluang. Notable movers as of Nov 03, 2026 04:11 WIB include Illumina (ILMN) at USD 236.73, down 18.39%, American Well Corp (AMWL) at USD 12.71, down 15.15% but with 100% buy orders, and Regeneron Pharmaceuticals (REGN) at USD 927.38, up 13.27% with 80% sell orders and 108 days typical hold time.
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
Century Communities announced the upcoming Shell Creek Manor community in Clinton, SC, offering 139 new single-family homes starting from the mid $200,000s. These homes feature flexible floor plans with 3 to 5 bedrooms, open-concept layouts, quartz c...
Thornburg Income Builder Opportunities Trust announced a monthly distribution of $0.10417 per share payable on November 20, 2026, to shareholders of record as of November 12, 2026. This distribution includes a return of capital and short-term capital...
